Top Markets
Coin of the day
Clearbridge Health Limited Clearbridge Health Limited

Clearbridge Health Limited

1H3
Classificação em ações #32402
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited... Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Preço da ação
$0.00158262
Última sincronização: 2026-08-17
Valor de mercado
$10.20M
Variação (1 dia)
0.00%
Variação (1 ano)
-
País
SG
Negociar Clearbridge Health Limited (1H3)

Categoria

Lucros da Clearbridge Health Limited (1H3)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Clearbridge Health Limited, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Clearbridge Health Limited de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US